Palvella Therapeutics, Inc. (PVLA) Change in Acquisitions & Divestments (2018 - 2022)
Palvella Therapeutics (PVLA) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $9.0 million as the latest value for Q1 2024.
- On a quarterly basis, Change in Acquisitions & Divestments fell 33.31% to $9.0 million in Q1 2024 year-over-year; TTM through Sep 2024 was $20.0 million, a 34.01% decrease, with the full-year FY2023 number at $35.0 million, up 24.14% from a year prior.
- Change in Acquisitions & Divestments was $9.0 million for Q1 2024 at Palvella Therapeutics, down from $11.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $28.4 million in Q1 2020 to a low of $4.8 million in Q2 2022.
- A 4-year average of $13.0 million and a median of $12.2 million in 2023 define the central range for Change in Acquisitions & Divestments.
- Peak YoY movement for Change in Acquisitions & Divestments: skyrocketed 898.35% in 2020, then plummeted 70.02% in 2023.
- Palvella Therapeutics' Change in Acquisitions & Divestments stood at $15.8 million in 2020, then tumbled by 60.0% to $6.3 million in 2022, then surged by 74.62% to $11.0 million in 2023, then dropped by 18.19% to $9.0 million in 2024.
- Per Business Quant, the three most recent readings for PVLA's Change in Acquisitions & Divestments are $9.0 million (Q1 2024), $11.0 million (Q4 2023), and $5.1 million (Q3 2023).